<?xml version="1.0" encoding="UTF-8"?>
<ref id="ddr21709-bib-0150">
 <mixed-citation publication-type="journal" id="ddr21709-cit-0150">
  <string-name>
   <surname>Sheahan</surname>, 
   <given-names>T. P.</given-names>
  </string-name>, 
  <string-name>
   <surname>Sims</surname>, 
   <given-names>A. C.</given-names>
  </string-name>, 
  <string-name>
   <surname>Zhou</surname>, 
   <given-names>S.</given-names>
  </string-name>, 
  <string-name>
   <surname>Graham</surname>, 
   <given-names>R. L.</given-names>
  </string-name>, 
  <string-name>
   <surname>Pruijssers</surname>, 
   <given-names>A. J.</given-names>
  </string-name>, 
  <string-name>
   <surname>Agostini</surname>, 
   <given-names>M. L.</given-names>
  </string-name>, … 
  <string-name>
   <surname>Baric</surname>, 
   <given-names>R. S.</given-names>
  </string-name> (
  <year>2020</year>). 
  <article-title>An orally bioavailable broad‐spectrum antiviral inhibits SARS‐CoV‐2 in human airway epithelial cell cultures and multiple coronaviruses in mice</article-title>. 
  <source xml:lang="en">Science Translational Medicine</source>, 
  <volume>12</volume>(
  <issue>541</issue>), 
  <elocation-id>eabb5883</elocation-id>
  <pub-id pub-id-type="doi">10.1126/scitranslmed.abb5883%J</pub-id>
  <pub-id pub-id-type="pmid">32253226</pub-id>
 </mixed-citation>
</ref>
